Статья: Разработка и свойства нового носителя доксорубицина на основе поверхностно-модифицированных микрочастиц ноль-валентного железа с высокой эффективностью инкапсуляции и возможностью его контролируемого высвобождения

Внимание! Если размещение файла нарушает Ваши авторские права, то обязательно сообщите нам

9. Farokhzad O.C., Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009; 3 (1): 16-20. DOI: 10.1021/ nn900002m.

10. Lv S., Li M., Tang Z., Song W., Sun H., Liu H., Chen X. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Acta Biomater. 2013; 9 (12): 9330-9342. DOI: 10.1016/j.actbio.2013.08.015.

11. Lee C.S., Kim H., Yu J., Yu S.H., Ban S., Oh S., Jeong D., Im J., Baek M.J., Kim T.H. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: a promising in vivo drug delivery system for colorectal cancer therapy. Eur. J. Med. Chem. 2017; 142: 416-423. DOI: 10.1016/j. ejmech.2017.08.063.

12. Di Martino A., Guselnikova O.A., Trusova M.E., Post- nikov P.S., Sedlarik V. Organic-inorganic hybrid nanoparticles controlled delivery system for anticancer drugs. Int. J. Pharm. 2017; 526 (1-2): 380-390. DOI: 10.1016/j.ijpharm.2017.04.061.

13. Kiraly R., Martin R.B. Metal ion binding to daunorubicin and quinizarin. Inorg. Chim. Acta. 1982; 67: 13-18.

14. Gallois L., Fiallo M., Garnier-Suillerot A. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles circular dichroism study. Biochim. Biophys. Acta Biomembr. 1998; 1370 (1): 31-40.

15. Pavinatto F.J., Caseli L., Oliveira O.N. Jr. Chitosan in nanostructured thin films. Biomacromolecules. 2010; 11 (8): 1897-1908. DOI: 10.1021/bm1004838.

16. Croisier F., Jйrфme C. Chitosan-based biomaterials for tissue engineering. Eur. Polymer J. 2013; 49 (4): 780-792.

17. Yang W., Fu J., Wang T., He N. Chitosan/Sodium tripolyphosphate nanoparticles: preparation, characterization and application as drug carrier. J. Biomed Nano- technol. 2009; 5 (5): 591-595.

18. Xu Y., Zhang X.Y., Hsing Y.M., Fang Y.Z. Ultrasonic-as- sisted synthesis of fe nanoparticles in the presence of Poly (N-vinyl-2-pyrrolidone). Chinese J. Chem. 2011; 29: 1829-1836.

19. Filimonov V.D., Trusova M.E., Postnikov P.S., Krasno- kutskaya E.A., Lee Y. M., Hwang H. Y., Kim H., Chi K. W. Unusually stable, versatile, and pure arene diazonium tosylates: their preparation, structures, and synthetic applicability. Org. Lett. 2008; 10 (18): 3961-3964. DOI: 10.1021/ol8013528.

20. Guselnikova O.A., Galanov A.I., Gutakovskii A.K., Post- nikov P.S. The convenient preparation of stable aryl-coated zerovalent iron nanoparticles. Beilstein J. Nano- technol. 2015; 6: 1192-1198. DOI: 10.3762/bjnano. 6.121.

21. Fang C., Kievit F.M., Veiseh O., Stephen Z.R., Wang T., Lee D., Ellenbogen R.G., Zhang M. Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach. J. Control Release. 2012; 162 (1): 233-241. DOI: 10.1016/j.jcon- rel.2012.06.028.

22. Soares P.I.P., Sousa A.I., Ferreira I.M.M., Novo C.M.M., Borges J.P. Towards the development of multifunctional chitosan-based iron oxide nanoparticles: Optimization and modelling of doxorubicin release. Carbohydr. Polym. 2016; 153 (20): 212-221. DOI: 10.1016/j.carb- pol.2016.07.109.

23. Prodan A.M., Iconaru S.L., Ciobanu C.S., Chifiriuc M.C., Stoicea M., Predoi D. Iron oxide magnetic nanoparticles: characterization and toxicity evaluation by in vitro and in vivo assays. Journal of Nanomaterials. 2013; 2013: 10. DOI: 10.1155/2013/587021.

24. Chehimi M.M., Lamouri A., Picot M., Pinson J. Surface modification of polymers by reduction of diazonium salts. The example of polymethylmethacrylate. J. Mater. Chem. C. 2014; 2: 356-363. DOI: 10.1039/C3TC31492H.

25. Paulusse J.M.J., Sijbesma R.P. Ultrasound in polymer chemistry: Revival of an established technique. Journal of Polymer Science Part A: Polymer Chemistry. 2006; 44 (19): 5445-5453. DOI: 10.1002/pola.21646.